Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study
et al., Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105552
In Silico study showing showing significant inhibitory potential of curcumin for omicron.
Nag et al., 5/1/2022, India, South Asia, peer-reviewed, 4 authors.
Contact:
anish.nag@christuniversity.in.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.